Treatment of a pituitary metastasis from a neuroendocrine tumour

Case report and literature review

Umberto Goglia, Diego Ferone, Marilena Sidoti, Renato Spaziante, Patrizia Dadati, Jean Luis Ravetti, Giuseppe Villa, Lisa Bodei, Giovanni Paganelli, Francesco Minuto, Massimo Giusti

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Herein we report a rare case of a pituitary metastasis from a neuroendocrine tumour mimicking an adenoma. Moreover, starting from this unusual case, the relevant literature concerning the diagnosis and management of patients with metastasis at pituitary level is reviewed. A 69-year-old woman was admitted to our Unit for severe headache, diplopia, and critical visual field impairment. MRI showed a large pituitary mass compressing the optic chiasm and infiltrating the cavernous sinus. Trans-sphenoidal biopsy revealed a pituitary metastasis from a neuroendocrine tumour, in line with the multiple liver lesions that were already considered metastases from an ileal primary neuroendocrine tumour. In vitro receptor characterisation of both pituitary and liver tissues by immunohistochemistry showed a heterogeneous somatostatin receptor subtype pattern, with a predominant expression of sst2 within the pituitary lesion. However, the liver metastasis receptor profile was completely different from the pituitary. Octreotide LAR was administered first, followed by receptor radiometabolic therapy with radiolabelled somatostatin analogues (90Y-DOTATOC and 177Lu-DOTATATE). After 16 months, MRI showed a significant shrinkage of the sellar mass. Moreover, disappearance of diplopia and visual defects, together with a considerable improvement in quality of life were gradually recorded. To our knowledge, this is the first case of combined treatment using 'cold' and radiolabelled octreotide in a pituitary metastasis from a neuroendocrine tumour.

Original languageEnglish
Pages (from-to)93-102
Number of pages10
JournalPituitary
Volume11
Issue number1
DOIs
Publication statusPublished - Mar 2008

Fingerprint

Neuroendocrine Tumors
Neoplasm Metastasis
Diplopia
Octreotide
Liver
Therapeutics
Optic Chiasm
Cavernous Sinus
Somatostatin Receptors
Vision Disorders
Somatostatin
Visual Fields
Adenoma
Headache
Immunohistochemistry
Quality of Life
Biopsy

Keywords

  • Lu-DOTATATE
  • Y-DOTATOC
  • Neuroendocrine tumours
  • Octreotide
  • Pituitary mass

ASJC Scopus subject areas

  • Endocrinology

Cite this

Goglia, U., Ferone, D., Sidoti, M., Spaziante, R., Dadati, P., Ravetti, J. L., ... Giusti, M. (2008). Treatment of a pituitary metastasis from a neuroendocrine tumour: Case report and literature review. Pituitary, 11(1), 93-102. https://doi.org/10.1007/s11102-007-0038-6

Treatment of a pituitary metastasis from a neuroendocrine tumour : Case report and literature review. / Goglia, Umberto; Ferone, Diego; Sidoti, Marilena; Spaziante, Renato; Dadati, Patrizia; Ravetti, Jean Luis; Villa, Giuseppe; Bodei, Lisa; Paganelli, Giovanni; Minuto, Francesco; Giusti, Massimo.

In: Pituitary, Vol. 11, No. 1, 03.2008, p. 93-102.

Research output: Contribution to journalArticle

Goglia, U, Ferone, D, Sidoti, M, Spaziante, R, Dadati, P, Ravetti, JL, Villa, G, Bodei, L, Paganelli, G, Minuto, F & Giusti, M 2008, 'Treatment of a pituitary metastasis from a neuroendocrine tumour: Case report and literature review', Pituitary, vol. 11, no. 1, pp. 93-102. https://doi.org/10.1007/s11102-007-0038-6
Goglia, Umberto ; Ferone, Diego ; Sidoti, Marilena ; Spaziante, Renato ; Dadati, Patrizia ; Ravetti, Jean Luis ; Villa, Giuseppe ; Bodei, Lisa ; Paganelli, Giovanni ; Minuto, Francesco ; Giusti, Massimo. / Treatment of a pituitary metastasis from a neuroendocrine tumour : Case report and literature review. In: Pituitary. 2008 ; Vol. 11, No. 1. pp. 93-102.
@article{dde98ecc25d74397821cf37185bdc9cf,
title = "Treatment of a pituitary metastasis from a neuroendocrine tumour: Case report and literature review",
abstract = "Herein we report a rare case of a pituitary metastasis from a neuroendocrine tumour mimicking an adenoma. Moreover, starting from this unusual case, the relevant literature concerning the diagnosis and management of patients with metastasis at pituitary level is reviewed. A 69-year-old woman was admitted to our Unit for severe headache, diplopia, and critical visual field impairment. MRI showed a large pituitary mass compressing the optic chiasm and infiltrating the cavernous sinus. Trans-sphenoidal biopsy revealed a pituitary metastasis from a neuroendocrine tumour, in line with the multiple liver lesions that were already considered metastases from an ileal primary neuroendocrine tumour. In vitro receptor characterisation of both pituitary and liver tissues by immunohistochemistry showed a heterogeneous somatostatin receptor subtype pattern, with a predominant expression of sst2 within the pituitary lesion. However, the liver metastasis receptor profile was completely different from the pituitary. Octreotide LAR was administered first, followed by receptor radiometabolic therapy with radiolabelled somatostatin analogues (90Y-DOTATOC and 177Lu-DOTATATE). After 16 months, MRI showed a significant shrinkage of the sellar mass. Moreover, disappearance of diplopia and visual defects, together with a considerable improvement in quality of life were gradually recorded. To our knowledge, this is the first case of combined treatment using 'cold' and radiolabelled octreotide in a pituitary metastasis from a neuroendocrine tumour.",
keywords = "Lu-DOTATATE, Y-DOTATOC, Neuroendocrine tumours, Octreotide, Pituitary mass",
author = "Umberto Goglia and Diego Ferone and Marilena Sidoti and Renato Spaziante and Patrizia Dadati and Ravetti, {Jean Luis} and Giuseppe Villa and Lisa Bodei and Giovanni Paganelli and Francesco Minuto and Massimo Giusti",
year = "2008",
month = "3",
doi = "10.1007/s11102-007-0038-6",
language = "English",
volume = "11",
pages = "93--102",
journal = "Pituitary",
issn = "1386-341X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - Treatment of a pituitary metastasis from a neuroendocrine tumour

T2 - Case report and literature review

AU - Goglia, Umberto

AU - Ferone, Diego

AU - Sidoti, Marilena

AU - Spaziante, Renato

AU - Dadati, Patrizia

AU - Ravetti, Jean Luis

AU - Villa, Giuseppe

AU - Bodei, Lisa

AU - Paganelli, Giovanni

AU - Minuto, Francesco

AU - Giusti, Massimo

PY - 2008/3

Y1 - 2008/3

N2 - Herein we report a rare case of a pituitary metastasis from a neuroendocrine tumour mimicking an adenoma. Moreover, starting from this unusual case, the relevant literature concerning the diagnosis and management of patients with metastasis at pituitary level is reviewed. A 69-year-old woman was admitted to our Unit for severe headache, diplopia, and critical visual field impairment. MRI showed a large pituitary mass compressing the optic chiasm and infiltrating the cavernous sinus. Trans-sphenoidal biopsy revealed a pituitary metastasis from a neuroendocrine tumour, in line with the multiple liver lesions that were already considered metastases from an ileal primary neuroendocrine tumour. In vitro receptor characterisation of both pituitary and liver tissues by immunohistochemistry showed a heterogeneous somatostatin receptor subtype pattern, with a predominant expression of sst2 within the pituitary lesion. However, the liver metastasis receptor profile was completely different from the pituitary. Octreotide LAR was administered first, followed by receptor radiometabolic therapy with radiolabelled somatostatin analogues (90Y-DOTATOC and 177Lu-DOTATATE). After 16 months, MRI showed a significant shrinkage of the sellar mass. Moreover, disappearance of diplopia and visual defects, together with a considerable improvement in quality of life were gradually recorded. To our knowledge, this is the first case of combined treatment using 'cold' and radiolabelled octreotide in a pituitary metastasis from a neuroendocrine tumour.

AB - Herein we report a rare case of a pituitary metastasis from a neuroendocrine tumour mimicking an adenoma. Moreover, starting from this unusual case, the relevant literature concerning the diagnosis and management of patients with metastasis at pituitary level is reviewed. A 69-year-old woman was admitted to our Unit for severe headache, diplopia, and critical visual field impairment. MRI showed a large pituitary mass compressing the optic chiasm and infiltrating the cavernous sinus. Trans-sphenoidal biopsy revealed a pituitary metastasis from a neuroendocrine tumour, in line with the multiple liver lesions that were already considered metastases from an ileal primary neuroendocrine tumour. In vitro receptor characterisation of both pituitary and liver tissues by immunohistochemistry showed a heterogeneous somatostatin receptor subtype pattern, with a predominant expression of sst2 within the pituitary lesion. However, the liver metastasis receptor profile was completely different from the pituitary. Octreotide LAR was administered first, followed by receptor radiometabolic therapy with radiolabelled somatostatin analogues (90Y-DOTATOC and 177Lu-DOTATATE). After 16 months, MRI showed a significant shrinkage of the sellar mass. Moreover, disappearance of diplopia and visual defects, together with a considerable improvement in quality of life were gradually recorded. To our knowledge, this is the first case of combined treatment using 'cold' and radiolabelled octreotide in a pituitary metastasis from a neuroendocrine tumour.

KW - Lu-DOTATATE

KW - Y-DOTATOC

KW - Neuroendocrine tumours

KW - Octreotide

KW - Pituitary mass

UR - http://www.scopus.com/inward/record.url?scp=38649104477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38649104477&partnerID=8YFLogxK

U2 - 10.1007/s11102-007-0038-6

DO - 10.1007/s11102-007-0038-6

M3 - Article

VL - 11

SP - 93

EP - 102

JO - Pituitary

JF - Pituitary

SN - 1386-341X

IS - 1

ER -